Projects and Grants per year
Grants and Contracts Details
Description
Patients with relapsed Acute Lymphoblastic Leukemia (ALL) have a poor prognosis because
their therapeutic options are limited. Relapse is thought to arise from leukemia stem cells, which have
the unique ability to self-renew to reform tumor from a single cell. These cells are rare in human
disease and mouse models, making up
| Status | Finished |
|---|---|
| Effective start/end date | 7/1/14 → 4/30/17 |
Funding
- National Institute of General Medical Sciences
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Projects
- 1 Finished
-
COBRE for the Center for Molecular Medicine
Hersh, L. (PI), Creamer, T. (CoI), Dutch, R. (CoI), Mendenhall, M. (CoI), Rodgers, D. (CoI), Spielmann, H. (CoI), Watt, D. (CoI), Zhu, H. (CoI) & Whiteheart, S. (Former CoI)
National Institute of General Medical Sciences
7/1/14 → 4/30/17
Project: Research project